Published: 29 June 2020

Committees

Comments on agenda items for the 64th meeting of the Medicines Classification Committee to be held on 9 July 2020

The Medicines Classification Committee and the Secretary wish to thank everyone for their valuable input and feedback.

A total of 28 submissions commenting on agenda items for the 64th meeting was received (PDF, 12.8 MB, 111 pages). Some submissions commented on more than one agenda item. One submission and some parts of the comments and have been withheld from publication for reasons described under clause 2b of the Official Information Act 1982.

Agenda item 5.3 Alkyl Nitrates

Ten comments were received about this agenda item.

Agenda item 6.1 Human Papillomavirus (HPV) vaccine – proposed change to the prescription classification statement (Pharmaceutical Society of New Zealand, the Pharmacy Guild of New Zealand and Green Cross Health)

Nine comments were received about this agenda item.

Agenda item 6.2 Cetirizine - proposed change to the pack size limit (AFT Pharmaceuticals Limited)

One comment was received about this agenda item.

Agenda item 6.3 Pholcodine - reclassification from a pharmacy medicine to a restricted medicine (Medsafe)

Eight comments were received about this agenda item.